By unraveling the complex interplay between SPOP mutations and the AR signaling pathway, we aim to contribute to the ongoing efforts to improve our understanding of prostate cancer biology and enhance patient outcomes through more precise and effective therapeutic interventions. This evidence concerns the gene AR and Familial prostate cancer.